{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T16:21:29Z","timestamp":1793118089151,"version":"4.5.0"},"reference-count":30,"publisher":"American Society of Hematology","issue":"22","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,11,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Despite an increasing incidence of venous thromboembolism (VTE) in pediatric patients in tertiary care settings, relatively few pediatric physicians have experience with antithrombotic interventions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>These guidelines of the American Society of Hematology (ASH), based on the best available evidence, are intended to support patients, clinicians, and other health care professionals in their decisions about management of pediatric VTE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>ASH formed a multidisciplinary guideline panel that included 2 patient representatives and was balanced to minimize potential bias from conflicts of interest. The McMaster University GRADE Centre supported the guideline-development process, including updating or performing systematic evidence reviews (up to April of 2017). The panel prioritized clinical questions and outcomes according to their importance for clinicians and patients. The panel used the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach, including GRADE Evidence-to-Decision frameworks, to assess evidence and make recommendations, which were subject to public comment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The panel agreed on 30 recommendations, covering symptomatic and asymptomatic deep vein thrombosis, with specific focus on management of central venous access device\u2013associated VTE. The panel also addressed renal and portal vein thrombosis, cerebral sino venous thrombosis, and homozygous protein C deficiency.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Although the panel offered many recommendations, additional research is required. Priorities include understanding the natural history of asymptomatic thrombosis, determining subgroup boundaries that enable risk stratification of children for escalation of treatment, and appropriate study of newer anticoagulant agents in children.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2018024786","type":"journal-article","created":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T16:55:52Z","timestamp":1543337752000},"page":"3292-3316","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":441,"title":["American Society of Hematology 2018 Guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism"],"prefix":"10.1182","volume":"2","author":[{"given":"Paul","family":"Monagle","sequence":"first","affiliation":[{"name":"Department of Clinical Haematology, Royal Children\u2019s Hospital, University of Melbourne and Murdoch Children\u2019s Research Institute, VIC, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1742-0242","authenticated-orcid":false,"given":"Carlos A.","family":"Cuello","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada;"},{"name":"Tecnologico de Monterrey School of Medicine, Monterrey, Mexico;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin","family":"Augustine","sequence":"additional","affiliation":[{"name":"Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Bonduel","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology, Hospital de Pediatria \u201cProf. Dr. Juan P. Garrahan,\u201d Buenos Aires, Argentina;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo R.","family":"Brand\u00e3o","sequence":"additional","affiliation":[{"name":"Division of Haematology\/Oncology, Department of Pediatrics, The Hospital for Sick Children, Toronto, ON, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tammy","family":"Capman","sequence":"additional","affiliation":[{"name":"Melbourne, FL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony K. C.","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, McMaster University, Hamilton, ON, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila","family":"Hanson","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Medical College of Wisconsin and Critical Care Section, Children\u2019s Hospital of Wisconsin, Milwaukee, WI;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Male","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Medical University of Vienna, Vienna, Austria;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joerg","family":"Meerpohl","sequence":"additional","affiliation":[{"name":"Department of Medical Biometry and Statistics, Institute of Medical Biometry and Medical Informatics, University of Freiburg and University Medical Center Freiburg, Freiburg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Newall","sequence":"additional","affiliation":[{"name":"Department of Clinical Haematology and"},{"name":"Department of Nursing Research, Royal Children\u2019s Hospital, University of Melbourne, Murdoch Children\u2019s Research Institute, Melbourne, VIC, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah H.","family":"O\u2019Brien","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology\/Oncology, Nationwide Children\u2019s Hospital, The Ohio State University, Columbus, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Raffini","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Children\u2019s Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heleen","family":"van Ommen","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology, Sophia Children\u2019s Hospital Erasmus MC, Rotterdam, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Wiernikowski","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Pediatrics, McMaster Children\u2019s Hospital, McMaster University, Hamilton, ON, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzan","family":"Williams","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hospital for Sick Children, University of Toronto, Toronto, ON, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meha","family":"Bhatt","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Riva","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada;"},{"name":"Department of Family Medicine, McMaster University, Hamilton, ON, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yetiani","family":"Roldan","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Schwab","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reem A.","family":"Mustafa","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada;"},{"name":"Division of Nephrology and Hypertension, Department of Medicine, University of Kansas Medical Center, Kansas City, KS; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3448-0156","authenticated-orcid":false,"given":"Sara K.","family":"Vesely","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Epidemiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2018,11,27]]},"reference":[{"issue":"3","key":"2020021108401163200_B1","doi-asserted-by":"crossref","first-page":"E123","DOI":"10.1503\/cmaj.131237","article-title":"Guidelines 2.0: systematic development of a comprehensive checklist for a successful guideline enterprise","volume":"186","author":"Sch\u00fcnemann","year":"2014","journal-title":"CMAJ"},{"key":"2020021108401163200_B2","author":"Committee on Standards for Developing Trustworthy Clinical Practice Guidelines, Board on Health Care Services","year":"2011"},{"key":"2020021108401163200_B3","author":"Qaseem"},{"issue":"7","key":"2020021108401163200_B4","doi-asserted-by":"crossref","first-page":"548","DOI":"10.7326\/M14-1885","article-title":"Guidelines International Network: principles for disclosure of interests and management of conflicts in guidelines","volume":"163","author":"Sch\u00fcnemann","year":"2015","journal-title":"Ann Intern Med"},{"issue":"5","key":"2020021108401163200_B5","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.zefq.2012.05.017","article-title":"[GRADE guidelines: 1. Introduction\u2014GRADE evidence profiles and summary of findings tables]","volume":"106","author":"Langer","year":"2012","journal-title":"Z Evid Fortbild Qual Gesundhwes"},{"issue":"7650","key":"2020021108401163200_B6","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"5","key":"2020021108401163200_B7","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1182\/blood.V83.5.1251.1251","article-title":"Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE","volume":"83","author":"Andrew","year":"1994","journal-title":"Blood"},{"issue":"suppl 1","key":"2020021108401163200_B8","first-page":"OC422","article-title":"Thromboembolism in childhood: a prospective two-year BPSU study in the United Kingdom","volume":"1","author":"Gibson","year":"2003","journal-title":"Thromb Haemost"},{"issue":"5","key":"2020021108401163200_B9","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1067\/mpd.2001.118192","article-title":"Venous thromboembolism in childhood: a prospective two-year registry in The Netherlands","volume":"139","author":"van Ommen","year":"2001","journal-title":"J Pediatr"},{"key":"2020021108401163200_B10","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jpeds.2016.02.017","article-title":"Incidence trends and mortality from childhood venous thromboembolism: a population-based cohort study","volume":"172","author":"Sabapathy","year":"2016","journal-title":"J Pediatr"},{"issue":"4","key":"2020021108401163200_B11","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1542\/peds.2009-0768","article-title":"Dramatic increase in venous thromboembolism in children\u2019s hospitals in the United States from 2001 to 2007","volume":"124","author":"Raffini","year":"2009","journal-title":"Pediatrics"},{"issue":"6","key":"2020021108401163200_B12","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1203\/00006450-200006000-00013","article-title":"Outcome of pediatric thromboembolic disease: a report from the Canadian Childhood Thrombophilia Registry","volume":"47","author":"Monagle","year":"2000","journal-title":"Pediatr Res"},{"issue":"3","key":"2020021108401163200_B13","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/MOP.0000000000000084","article-title":"Venous thromboembolism in critically ill children","volume":"26","author":"Polikoff","year":"2014","journal-title":"Curr Opin Pediatr"},{"key":"2020021108401163200_B14","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3389\/fped.2017.00198","article-title":"Pediatric hospital acquired venous thromboembolism","volume":"5","author":"Witmer","year":"2017","journal-title":"Front Pediatr"},{"issue":"6","key":"2020021108401163200_B15","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/S0022-3476(98)70149-0","article-title":"Central venous catheter related thrombosis in children: analysis of the Canadian Registry of Venous Thromboembolic Complications","volume":"133","author":"Massicotte","year":"1998","journal-title":"J Pediatr"},{"issue":"10","key":"2020021108401163200_B16","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1080\/17474086.2016.1230012","article-title":"Novel perspectives on diagnosis and clinical significance of the post-thrombotic syndrome in children","volume":"9","author":"Jones","year":"2016","journal-title":"Expert Rev Hematol"},{"key":"2020021108401163200_B17","author":"Lo","year":"2009"},{"issue":"11","key":"2020021108401163200_B18","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.jclinepi.2014.05.006","article-title":"Considering intellectual, in addition to financial, conflicts of interest proved important in a clinical practice guideline: a descriptive study","volume":"67","author":"Akl","year":"2014","journal-title":"J Clin Epidemiol"},{"issue":"11","key":"2020021108401163200_B19","doi-asserted-by":"crossref","first-page":"738","DOI":"10.7326\/0003-4819-152-11-201006010-00254","article-title":"The vexing problem of guidelines and conflict of interest: a potential solution","volume":"152","author":"Guyatt","year":"2010","journal-title":"Ann Intern Med"},{"issue":"6","key":"2020021108401163200_B20","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1164\/rccm.200901-0126ST","article-title":"An official American Thoracic Society Policy statement: managing conflict of interest in professional societies","volume":"180","author":"Sch\u00fcnemann","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"2020021108401163200_B21","unstructured":"Bro\u017cek\n              J\n            , NowakA, KunstmanP, Sch\u00fcnemannHJ. GRADEpro Guideline Development Tool (computer program). Available at: www.guidelinedevelopment.org. Accessed 18 September 2015."},{"issue":"4","key":"2020021108401163200_B22","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jclinepi.2010.09.012","article-title":"GRADE guidelines: 2. Framing the question and deciding on important outcomes","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"2020021108401163200_B23","doi-asserted-by":"crossref","first-page":"i2016","DOI":"10.1136\/bmj.i2016","article-title":"GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction","volume":"353","author":"Alonso-Coello","year":"2016","journal-title":"BMJ"},{"key":"2020021108401163200_B24","doi-asserted-by":"crossref","first-page":"i2089","DOI":"10.1136\/bmj.i2089","article-title":"GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines","volume":"353","author":"Alonso-Coello","year":"2016","journal-title":"BMJ"},{"issue":"1","key":"2020021108401163200_B25","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1472-6963-4-38","article-title":"Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches The GRADE Working Group","volume":"4","author":"Atkins","year":"2004","journal-title":"BMC Health Serv Res"},{"issue":"4","key":"2020021108401163200_B26","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"2020021108401163200_B27","author":"Schunemann"},{"issue":"2 suppl","key":"2020021108401163200_B28","doi-asserted-by":"crossref","first-page":"e737S","DOI":"10.1378\/chest.11-2308","article-title":"Antithrombotic therapy in neonates and children: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Monagle","year":"2012","journal-title":"Chest"},{"issue":"9","key":"2020021108401163200_B29","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1111\/jth.13038","article-title":"Multicenter randomized controlled trial on Duration of Therapy for Thrombosis in Children and Young Adults (the Kids-DOTT trial): pilot\/feasibility phase findings","volume":"13","author":"Goldenberg","year":"2015","journal-title":"J Thromb Haemost"},{"key":"2020021108401163200_B30","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jclinepi.2016.09.009","article-title":"GRADE Evidence to Decision (EtD) frameworks for adoption, adaptation, and de novo development of trustworthy recommendations: GRADE-ADOLOPMENT","volume":"81","author":"Sch\u00fcnemann","year":"2017","journal-title":"J Clin Epidemiol"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/2\/22\/3292\/1629923\/advances024786cg.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/2\/22\/3292\/1629923\/advances024786cg.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T09:15:49Z","timestamp":1581412549000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/2\/22\/3292\/16093\/American-Society-of-Hematology-2018-Guidelines-for"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,27]]},"references-count":30,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2018,11,27]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2018024786","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,27]]}}}